Skip to main content

Table 1 Demographic and baseline characteristics of patients

From: Current diagnosis and treatment of acute pancreatitis in China: a real-world, multicenter study

Patients before and after inclusion variable Number of patients screened
(N = 3900)
Sex: male (%) 2329 (59.7)
Age, year (mean (sd)) 51.70 (17.19)
Age, years (median [IQR]) 51.00 [39.00, 65.00]
Age (%)
 [0,18] 61 (1.6)
 [18,65] 2854 (73.2)
 [65,80] 775 (19.9)
 [Above 80] 210 (5.4)
Smoking history (%)
 0 2795 (71.7)
 1 987 (25.3)
 Unknown 118 (3.0)
Drinking history (%)
 0 2804 (71.9)
 1 988 (25.3)
 Unknown 108 (2.8)
Medical history (%)
 History of pancreatitis 544 (13.9)
History of diabetes
 0 3140 (80.5)
 1 501 (12.8)
 Unknown 259 (6.6)
Comorbidity (%)
 With hyperlipidemia 587 (15.1)
 With cholelithiasis 1229 (31.5)
Etiology (%)
 Biliary 1861 (47.7)
 Hyperlipidemia 227 (5.8)
 High-fat diet 120 (3.1)
 Alcoholic 108 (2.8)
 Duration of the disease, days (mean (sd)) 6.77 (27.30)
 Days of illness, days (median [IQR]) 2.00 [1.00, 5.00]
Critical condition (%)
 Admitted to the hospital 559 (14.3)
 Discharge of critical illness 944 (24.2)
 Charlson Index (mean (sd)) 2.63 (2.08)
 Charlson Index (median [IQR]) 2.00 [1.00, 4.00]
Standardized medication (%)
 Standard medication 3049 (78.2)
 Unregulated medication 327 (8.4)
 Unused 524 (13.4)
Medical treatment (%)
 Somatostatin 1600 (41.0)
 Octreotide 892 (22.9)
 Somatostatin octreotide 884 (22.7)
 Unused 524 (13.4)
 Special treatment (%) 927 (23.8)
 Mechanical ventilation (%) 159 (4.1)
 CRRT (%) 218 (5.6)
 Local puncture drainage (%) 144 (3.7)
 Laparoscopy / laparotomy (%) 356 (9.1)
 ERCP (%) 268 (6.9)
 Length of hospital stay, days (mean (sd)) 13.97 (10.67)
 Length of hospital stay, days (median [IQR]) 11.00 [8.00, 17.00]
 Complications at discharge (%) 351 (9.0)
 Organ failure (%) 187 (4.8)
 All-cause Death (%) 49 (1.3)
 Enter ICU (%) 375 (9.6)